1. Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results
   Shinya Rai et al, 2022, Haematologica CrossRef
2. Advances and Perspectives in the Treatment of T-PLL
   Till Braun et al, 2020, Current Hematologic Malignancy Reports CrossRef
3. Targeted small molecule therapy and inhibitors for lymphoma
   Zhong-Hui Wang et al, 2024, Future Medicinal Chemistry CrossRef
4. The Status and Prospects of Epigenetics in the Treatment of Lymphoma
   Jiaxin Liu et al, 2022, Frontiers in Oncology CrossRef
5. Enhancers in T Cell development and malignant lesions
   Tong Zhang et al, 2024, Cell Death Discovery CrossRef
6. Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
   Suvankar Banerjee et al, 2021, Current Chemical Biology CrossRef